… to drug therapy [33]. Metabolomics can also help in evaluating drug resistance and disease
relapse [34,35], leading to opportunities for the development of novel therapeutic strategies […

… framework, most current-targeted therapy strategies against GIST are aimed against KIT …
the molecular basis of targeted therapy and personalized medicine in GIST, current treatment …

… therapeutic approach based on the personalized medicine allows to remedy similar situation
by setting from the beginning a therapy … therapies, adjusting the shot making the therapeutic …

… Examples of personalized medicine include using targeted therapies to treat specific types
of cancer cells, such as HER2‐positive breast cancer cells, or using tumor marker testing to …

… therapy and dosing correctly. This shows why so many decisions on using … therapy end up
as being personalized treatments. In addition, antibiotics can be used as prophylactic therapy …

… drug therapy used is chemotherapy but cancer cells may be able to develop resistance to the
effects of drugs and cause therapy … at clinical level in a personalized medicine prospective. …

… personalized medicines. We describe many areas where AI can play such a role and argue
that AI’s ability to advance personalized medicine … in developing personalized medicines as …

… The failure of animal models to predict therapeutic responses in humans is a major problem
… animal models for drug development and as living avatars for personalized medicine is ever …

… targeting a specific receptor over-expressed in a subpopulation of cells could represent a
suitable strategy to be further explored for personalized medicine therapeutic regimens. …

… The discipline of neurotheranostics was forged to improve diagnostic and therapeutic … system
disease therapeutic outcomes. However, obstacles in formulation design, drug loading and …